Corifollitropin alfa for poor responders patients, a prospective randomized study.
CONCLUSIONS: The long agonist protocol with the addition of rFSH and rLH showed the best results in all the parameters. A short antagonist protocol with CFA was less effective, but not significantly, although provided better results compared to the no-CFA group. We suggest that a long agonist protocol with CFA and recombinant gonadotropins might be a valuable option for poor responders.
TRIAL REGISTRATION: The study was approved by the local Ethics Committee (EudraCT2015-002817-31).
PMID: 32646462 [PubMed - in process]
Source: Reproductive Biology - Category: Reproduction Medicine Authors: Fusi FM, Zanga L, Arnoldi M, Melis S, Cappato M, Candeloro I, Di Pasqua A Tags: Reprod Biol Endocrinol Source Type: research
More News: Biology | Endocrinology | Medical Ethics | Ovaries | Pregnancy | Reproduction Medicine | Study